DayTwo · raw details

Precision Nutrition for Metabolic Disease · Tel Aviv-Yafo · Founded 2015

inactive Series C ← back to profile

Highlights

1 patentProfile claimed by owner

About

Precision Nutrition for Metabolic Disease

DayTwo is a microbiome-based precision health company committed to creating individualized solutions for the epidemic of chronic conditions, starting with diabetes, prediabetes, and clinical obesity.

Using the highest resolution microbiome analysis available and a unique artificial intelligence-based algorithm, DayTwo can accurately predict blood sugar response to foods or food combinations– before people even take a bite. Its clinically proven approach is based on the company's proprietary microbiome dataset. With over 85,000 samples, it is one of the largest and richest in the world.

Identity

NameDayTwo
Slugdaytwo
Former namesGeneEat
Type / kindstartup
Crunchbase IDdaytwo
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgL31np8LDA

Status

Statusinactive
Status reasonNon Active, Aug 2024 ceased to operate
Last update2026-05-17

Location

HQ country codeIL
HQ region/districtCenter District
HQ cityTel Aviv-Yafo
HQ addressYigal Alon Street 114, Tel Aviv-Yafo, Israel

Web & social

LinkedInhttps://www.linkedin.com/company/10304777
Twitter / Xhttps://twitter.com/daytwohealth
Facebookhttps://www.facebook.com/DayTwoHealth
YouTubehttps://www.youtube.com/channel/UC13SvDgFc7zKNkmHAp3pzjQ

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Technologies
Platforms & InterfacesMobileArtificial IntelligenceMachine LearningBiologicalsMicroorganisms
Target customers
Enterprise & Professional ServicesHuman Resource & Employment ServicesConsumersRecreational & LifestyleHealthcare & Life SciencesHealthcarePatientsProviders
Business models
B2B2CB2BB2C
Tags
personalizationfoodtechchronic-diseasedigital-healthcareobesitymhealthnutritionmachine-learningdiabetesmobile-applicationstype-2-diabetesdata-analyticsactionable-insightsprecision-medicinemicrobiomeartificial-intelligencenutrition-advicedigital-therapeuticsinsurance-companiesclinicshealthcare-providerspatients

Funding

Total raised$90.0M
Current stageSeries C

Raw source document

Show full JSON (0 KB)
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}